Original Article
Minimally invasive liver resection for huge (≥10 cm) tumors: an international multicenter matched cohort study with regression discontinuity analyses
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:587-597
.
(01 October 2021)
Impact of body mass index on hepatocellular carcinoma recurrence after liver transplantation through long-term follow-up
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:598-609
.
(01 October 2021)
1- Obesity should not be considered when selecting patients with HCC to LT as a predictive factor of HCC recurrence.
2- Recipient’s BMI at time of transplant had no direct impact on the incidence of HCC recurrence after LT, through long-term follow up, and regardless the status of the patients and their tumor characteristic at time of transplant.
2- Recipient’s BMI at time of transplant had no direct impact on the incidence of HCC recurrence after LT, through long-term follow up, and regardless the status of the patients and their tumor characteristic at time of transplant.
Accuracy of non-invasive liver stiffness measurement and steatosis quantification in patients with severe and morbid obesity
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:610-622
.
(01 October 2021)
Diagnostic accuracy for VCTE, CAP™ and FAST score to diagnose significant and advanced fibrosis, significant and severe steatosis and NASH is only acceptable in patients with BMI≥35 kg/m² but improved in the cohort of patients below the median BMI of 44.4 kg/m2.
Stereotactic body radiation therapy versus radiofrequency ablation in patients with small hepatocellular carcinoma: a systematic review and meta-analysis
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:623-630
.
(01 October 2021)
The meta-analysis demonstrated that SBRT provided a better effect on control of local tumor recurrence than RFA while RFA have a better survival rate than SBRT. Meanwhile, uniform standard of SBRT radiological dose and complications should be establish for further systematic review.
Transarterial infusion chemotherapy with FOLFOX for advanced hepatocellular carcinoma: a multi-center propensity score matched analysis of real-world practice
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:631-645
.
(01 October 2021)
Transarterial infusion chemotherapy with FOLFOX regimen is effective and safe in treatment of BCLC stage C hepatocellular carcinoma. Compared with transarterial chemoembolization and sorafenib, it could improve the patient survival and bring similar rates of adverse events.
Liver resection versus intensity-modulated radiation therapy for treatment of hepatocellular carcinoma with hepatic vein tumor thrombus: a propensity score matching analysis
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:646-660
.
(01 October 2021)
Surgery resulted in better survival in HCC patients with hepatic vein tumor thrombus compared to IMRT.
Review Article
Clinical practice of transarterial chemoembolization for hepatocellular carcinoma: consensus statement from an international expert panel of International Society of Multidisciplinary Interventional Oncology (ISMIO)
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:661-671
.
(01 October 2021)
This consensus aims to establish a guideline worldwide to standardized the clinical practice of TACE for hepatocellular carcinoma: The consensus statements were organized into the following categories: patients’ selection, performing the procedure, TACE outcomes, repeat TACE, TACE failure/refractory, and TACE–based combination treatments.
French Editorial from the ACHBPT
Comment on: local control and survival after induction chemotherapy and ablative radiation versus resection for pancreatic ductal adenocarcinoma with vascular involvement
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:672-674
.
(01 October 2021)
Comment on: liver venous deprivation (LVD) or associating liver partition and portal vein ligation for staged hepatectomy (ALPPS)? A retrospective multicentric study
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:675-677
.
(01 October 2021)
Editorial
You shall never walk alone: burnout and depression amongst healthcare professionals
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:678-681
.
(01 October 2021)
Interpretation of NCCN guidelines for hepatobiliary tumors V3 update in 2021
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:682-685
.
(01 October 2021)
Tailoring bacterial taxa for immune cell modulation
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:686-688
.
(01 October 2021)
Targeting resolvins in cholestatic liver injury
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:689-691
.
(01 October 2021)
The upward trend in the immunotherapy utilization for hepatobiliary cancers
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:692-695
.
(01 October 2021)
Commentary
Metabolic associated fatty liver disease (MAFLD): a milestone in the history of fatty liver disease
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:696-698
.
(01 October 2021)
Commentary on “Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial”
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:699-701
.
(01 October 2021)
Commentary on whole-grain intake and pancreatic cancer risk-the danish, diet, cancer and health cohort by Schacht et al.
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:702-704
.
(01 October 2021)
The paradox role of cytotoxic T-lymphocytes in NAFLD-associated hepatocellular carcinoma
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:705-707
.
(01 October 2021)
Beneficial effect of whole-grain wheat on liver fat: a role for the gut microbiota?
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:708-710
.
(01 October 2021)
Viewpoint
Synchronous colorectal liver metastases: therapeutic considerations
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:711-713
.
(01 October 2021)
Multimodality standard of care treatment of resectable and borderline resectable pancreatic cancer
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:714-716
.
(01 October 2021)
Optimization of immunotherapy for patients with hepatobiliary cancer
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:717-719
.
(01 October 2021)
Simultaneous resection of synchronous colorectal liver metastases: a promising alternative to staged resections
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:720-723
.
(01 October 2021)
New onset diabetes mellitus after liver transplantation
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:724-727
.
(01 October 2021)
Does neoadjuvant therapy improve survival in pancreatic adenocarcinoma?
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:728-730
.
(01 October 2021)
How to reduce and manage hepatic arterial complications in living and deceased donor liver transplantations
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:731-733
.
(01 October 2021)
Same soup different taste—how to best manage the future liver remnant—a surgical perspective
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:734-736
.
(01 October 2021)
Letter to the Editor
Donafenib as a first-line monotherapy for advanced hepatocellular carcinoma
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:737-740
.
(01 October 2021)
Integrative medicine and surgery: what are the diet and supplement recommendations for someone with pancreatic cancer?
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:741-743
.
(01 October 2021)
Images in Clinical Medicine
Acquired coarctation of abdominal aorta by hydatid disease
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:744-745
.
(01 October 2021)
Giant hepatic neuroendocrine tumor
HepatoBiliary Surgery and Nutrition
2021;
10
(5)
:746-747
.
(01 October 2021)
